tradingkey.logo

Solventum Corp

SOLV
78.120USD
+1.140+1.48%
Close 02/06, 16:00ETQuotes delayed by 15 min
13.55BMarket Cap
8.92P/E TTM

Solventum Corp

78.120
+1.140+1.48%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Solventum Corp

Currency: USD Updated: 2026-02-06

Key Insights

Solventum Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 66 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 89.37.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Solventum Corp's Score

Industry at a Glance

Industry Ranking
66 / 205
Overall Ranking
176 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Solventum Corp Highlights

StrengthsRisks
Solventum Corporation is a global healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer needs. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.
Undervalued
The company’s latest PE is 8.92, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 128.25M shares, decreasing 2.14% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 412.00 shares of this stock.

Analyst Rating

Based on 15 analysts
Buy
Current Rating
89.371
Target Price
+16.10%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Solventum Corp is 7.02, ranking 110 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 2.10B, representing a year-over-year increase of 0.67%, while its net profit experienced a year-over-year increase of 937.70%.

Score

Industry at a Glance

Previous score
7.02
Change
0

Financials

6.33

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.55

Operational Efficiency

8.18

Growth Potential

6.93

Shareholder Returns

7.13

Solventum Corp's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Solventum Corp is 6.51, ranking 160 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 8.92, which is 302.69% below the recent high of 35.92 and 23.94% above the recent low of 6.78.

Score

Industry at a Glance

Previous score
6.51
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 66/205
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Solventum Corp is 7.20, ranking 142 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 85.00, with a high of 103.00 and a low of 72.00.

Score

Industry at a Glance

Previous score
7.20
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 15 analysts
Buy
Current Rating
89.371
Target Price
+16.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

114
Total
6
Median
9
Average
Company name
Ratings
Analysts
Solventum Corp
SOLV
15
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Medtronic PLC
MDT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
23

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Solventum Corp is 6.94, ranking 72 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 84.60 and the support level at 73.41, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.77
Change
0.17

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.288
Sell
RSI(14)
46.543
Neutral
STOCH(KDJ)(9,3,3)
52.991
Buy
ATR(14)
1.796
Low Volatility
CCI(14)
-13.506
Neutral
Williams %R
55.167
Sell
TRIX(12,20)
-0.267
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
76.850
Buy
MA10
77.096
Buy
MA20
79.064
Sell
MA50
81.084
Sell
MA100
76.984
Buy
MA200
74.829
Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Solventum Corp is 7.00, ranking 80 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 73.94%, representing a quarter-over-quarter increase of 9.94%. The largest institutional shareholder is The Vanguard, holding a total of 16.96M shares, representing 9.78% of shares outstanding, with 4.63% increase in holdings.

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
3M Co
25.57M
-25.60%
The Vanguard Group, Inc.
Star Investors
17.05M
+5.32%
Independent Franchise Partners LLP
12.90M
+27.20%
Trian Fund Management, L.P.
Star Investors
8.46M
--
BlackRock Institutional Trust Company, N.A.
7.43M
+7.22%
State Street Investment Management (US)
6.22M
+1.84%
Davis Selected Advisers, L.P.
Star Investors
5.52M
+0.45%
Boston Partners
4.63M
+26.14%
Geode Capital Management, L.L.C.
3.83M
+7.34%
Invesco Capital Management LLC
Star Investors
2.50M
+6.79%
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Solventum Corp is 9.03, ranking 14 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Solventum Corp’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

Score

Industry at a Glance

Previous score
9.03
Change
0
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
+25.02%
240-Day Volatility
+31.67%

Return

Best Daily Return
60 days
+4.26%
120 days
+7.91%
5 years
--
Worst Daily Return
60 days
-6.61%
120 days
-6.61%
5 years
--
Sharpe Ratio
60 days
+1.51
120 days
+0.64
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+25.02%
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
+0.10
3 years
--
5 years
--
Skewness
240 days
+0.57
3 years
--
5 years
--

Volatility

Realised Volatility
240 days
+31.67%
5 years
--
Standardised True Range
240 days
+2.55%
5 years
--
Downside Risk-Adjusted Return
120 days
+99.97%
240 days
+99.97%
Maximum Daily Upside Volatility
60 days
+19.76%
Maximum Daily Downside Volatility
60 days
+18.46%

Liquidity

Average Turnover Rate
60 days
+0.54%
120 days
+0.63%
5 years
--
Turnover Deviation
20 days
--
60 days
--
120 days
--

Peer Comparison

Healthcare Equipment & Supplies
Solventum Corp
Solventum Corp
SOLV
7.16 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Becton Dickinson and Co
Becton Dickinson and Co
BDX
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Align Technology Inc
Align Technology Inc
ALGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI